Induced pluripotent stem cells are reprogrammed from somatic cells to mimic embryonic stem cell properties. They offer scalable, patient-specific models for disease research, drug screening, and regenerative therapies. With the ability to differentiate into various cell types, iPSCs support customized studies in developmental biology, toxicity testing, and therapeutic innovation—without the ethical concerns of embryonic sources.
